Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > dumping at $0.57

<< Previous

Bullboard Posts

Next >>

Comment by RazeKreationson May 27, 2021 11:07am

99 Views

Post# 33275473

RE:dumping at $0.57

Good riddance and goodbye. The $1.80 forecast is for end of fiscal 2022. That may sound like a long way away but that is only 16 months from now. Whoever is buying knows that and they can see the value.

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program